Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes-a substudy of the TROPICAL-ACS trial.

European heart journal. Cardiovascular pharmacotherapy(2023)

引用 0|浏览39
暂无评分
摘要
The strategy of guided DAPT de-escalation was associated with a significant net clinical benefit in non-overweight patients, while the two strategies were equivalent in overweight patients.
更多
查看译文
关键词
Acute coronary syndromes,Antiplatelet therapy,Platelet function testing,Prasugrel
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要